The clinical significance of serum soluble interleukin-2 receptors in lung cancer

Lung Cancer

Volumn 15, Issue 1, 1996, Pages 79-84

  Yano, Tokujiro ^a   Yoshino, Ichiro ^a   Yokoyama, Hideki ^a   Fukuyama, Yasuro ^a   Takai, Eiji ^a   Asoh, Hiroshi ^a   Ichinose, Yukito ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

Enzyme immunoassay; Lung cancer; Soluble interleukin 2 receptor

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0030221362     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-5002(96)00572-7     Document Type: Article

References (8)

1. [1] Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135: 3172-3177.
2. [2] Rubin LA, Jay G, Nelson DL. The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol 1986; 137: 3841-3844.
3. [3] Wagner DK, Kiwanuka J, Edwards BK, Rubin LA, Nelson DL, Magrath IT. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. J Clin Oncol 1987; 5: 1262-1274.
4. [4] Pizzolo G, Chilosi M, Vinante F, Dazzi F, Lestani M, Perona G, Benedetti F, Todeschini G, Vincenzi C, Trentin L, Semenzato G. Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease. Br J Cancer 1987; 55: 427-428.
5. [5] Lissoni P, Barni S, Rovelli F, Viviani S, Maestroni GJM, Conti A, Tancini G. The biological significance of soluble interleukin-2 receptors in solid tumors. Eur J Cancer 1990; 26: 33-36.
6. [6] Marino P, Cugno M, Preatoni A, Cori P, Rosti A, Frontini L, Cicardi M. Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer. Br J Cancer 1990; 61: 434-435.
7. [7] Tisi E, Lissoni P, Angeli M, Arrigoni C, Corno E, Cassina E, Ballabio D, Benenti C, Barni S, Tancini G. Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma. Cancer 1992; 69: 2458-2462.
8. [8] Mountain CF. A new international staging system for lung cancer. Chest 1986; 89 (Suppl): 225S-233S.